Soon after releasing its “Autumn Statement” in November, the UK unveiled its “Strategy for the UK Life Sciences.” The reports detail the UK’s plans for furthering economic growth and encouraging foreign investment. The “Strategy for the UK Life Sciences” outlines plans to benefit the industry. The government has designated £310 million ($500 million = £0.62 […]
ASD is a company confident in its future. The combination of the firm’s portable instruments, application experience and two decades in natural resource management, as well as high natural resource commodity prices, has boosted its management team’s confidence that its compound annual growth rate will be above 25% over the next five years—perhaps higher, if […]
Metrohm sets itself apart from other companies. Its business structure is not one that many instrument firms choose to emulate, but it has served the company well for decades. In fact, the firm estimates its 2011 revenues to be CHF 300 million ($333.3 million = CHF 0.90 = $1). Metrohm is unique because of the […]
Third-quarter 2011 IBO Life Science Index sales grew 6.7%, 4.6% excluding currency, to $3,149.7 million. Operating profit improved 2.1% to $641.8 million, and operating margin slipped 90 basis points to 21.4% of sales. Fiscal fourth-quarter revenue for Becton Dickinson’s BD Biosciences division grew 9.6%, 4.7% excluding currency, to $354.2 million to account for 17% of […]
On November 30, the European Commission unveiled its proposal for Horizon 2020, the EU’s €79,271 million ($105,713 million = €0.75 = $1) R&D program for 2014 through 2020. The program aims to unite existing EU research programs, simplify and streamline EU funding for R&D, and promote strategic priorities. The program encompasses major EU mechanisms for […]
In its broadest sense, correlative microscopy refers to the combination of multiple microscopy techniques to observe the same structure or event. Recent announcements by two major microscopy providers suggest that correlative microscopy will be a focus of their businesses in coming years. Although correlative microscopy can take many forms, the use of light microscopy (LM) […]
For most of November, global equity prices slumped due to heightened apprehensions over European sovereign debt and unsustainable Treasury bond yields for those debt-ridden countries. In the US, positive economic data for the consumer sector and manufacturing was overshadowed by Europe and uncertainty surrounding the Congressional budget reduction. However, amid the anguish, the Federal Reserve […]
Slower academic and government spending continued into the calendar-year third quarter, with mixed effects on the eight businesses whose quarterly results are profiled on pages 9–11. Industrial and applied markets stayed strong, as did Asia, helping sustain momentum for all companies, with the exception of Illumina. Combined sales growth for the eight businesses (including a […]
The US fiscal year 2012 began in October, but details of the federal government’s budget are still being ironed out. The $193 billion fiscal 2012 “minibus” appropriations bill, which covers five federal departments and various independent agencies, was passed by the House and Senate on November 17 and signed by President Obama the next day. […]
Subvisible particles are a concern in the biopharmaceutical industry due to their possible correlation with immunogenicity. The impact of subvisible particles on biologics is unknown but potentially adverse, and is complicated by the lack of technologies that can adequately measure them. Subvisible particles are usually defined as those that are too big for analysis with […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
